热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　精优药业（00858）发布公告，于2025年12月19日，公司根据其于2022年9月2日采纳的购股权计划，向合共3名承授人（即程勇先生、楼屹博士及郭懿博士，彼等均为执行董事）提呈授出合共7650万份购股权。购股权的行使价为每股0.0936港元。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.